SEC Form 4 · accession 0001615774-18-004821
Motus GI Holdings, Inc. · MOTS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Darren Sherman
Director
Period of report
May 31, 2018
Accepted (ET)
Jun 4, 2018 · 4:31 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001686850
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.0001 per shareF1,F2 | May 31, 2018 | J | 1,000,000 | — | D | 109,792 | I | By Orchestra Medical Ventures II, L.P. |
| Common Stock, par value $0.0001 per shareF3,F4 | May 31, 2018 | J | 2,000,000 | — | A | 2,000,000 | I | By Orchestra BioMed, Inc. |
| Common Stock, par value $0.0001 per share | holding | — | — | — | 9,000 | D | ||
| Common Stock, par value $0.0001 per shareF5 | holding | — | — | — | 1,159,968 | I | By Orchestra MOTUS Co-Investment Partners, LLC | |
| Common Stock, par value $0.0001 per shareF6 | holding | — | — | — | 83,352 | I | By Orchestra Medical Ventures II Reserve, L.P. | |
| Common Stock, par value $0.0001 per shareF7 | holding | — | — | — | 51,498 | I | By Accelerated Technologies, Inc. |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The securities are directly held by Orchestra Medical Ventures II, L.P. ("OMV II"). Orchestra Medical Ventures II GP, LLC ("OMV GP") serves as general partner to OMV II. Reporting Person and David Hochman are the managing members of OMV GP. OMV II exchanged 1,000,000 shares of Common Stock of Motus GI Holdings, Inc. in return for 1,000,000 shares of Series A Preferred Stock of Orchestra BioMed, Inc., a Delaware corporation ("OBIO").
- F2The securities are directly held by OMV II. OMV GP serves as general partner to OMV II. Reporting Person and Mr. Hochman are the managing members of OMV GP. Reporting Person and Mr. Hochman jointly exercise dispositive and voting power over the shares owned by OMV II. Each of Reporting Person, Mr. Hochman and OMV GP disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934 ("Section 16"), beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Reporting Person, Mr. Hochman or OMV GP is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.
- F3The securities are directly held by OBIO. Reporting Person, Mr. Hochman and Geoffrey W. Smith are the directors of OBIO. OBIO exchanged 2,000,000 shares of Series A Preferred Stock of OBIO in return for (a) 1,000,000 shares of Common Stock of Motus GI Holdings, Inc. from OMV II and (b) 1,000,000 shares of Common Stock of Motus GI Holdings, Inc. from Ascent Biomedical Ventures II, L.P.
- F4The securities are directly held by OBIO. Reporting Person, Mr. Hochman and Mr. Smith are the directors of OBIO. Reporting Person, Mr. Hochman and Mr. Smith jointly exercise dispositive and voting power over the shares owned by OBIO. Each of Reporting Person, Mr. Hochman and Mr. Smith disclaims, for purposes of Section 16, beneficial ownership of such securities, except to the extent of their indirect pecuniary interest therein, and this report shall not be deemed an admission that either Reporting Person, Mr. Hochman or Mr. Smith are the beneficial owners of such securities for purposes of Section 16 or for any other purposes.
- F5The securities are directly held by Orchestra MOTUS Co-Investment Partners, LLC ("OMCP"). Orchestra Medical Ventures, LLC ("OMV LLC") serves as managing member to OMCP. Reporting Person and Mr. Hochman are the managing partners of OMV LLC. Reporting Person and Mr. Hochman jointly exercise dispositive and voting power over the shares owned by OMCP. Each of Reporting Person, Mr. Hochman and OMV LLC disclaims, for purposes of Section 16, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Reporting Person, Mr. Hochman or OMV LLC is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.
- F6The securities are directly held by Orchestra Medical Ventures II Reserve, L.P. ("OMV Reserve"). OMV GP serves as general partner to OMV Reserve. Reporting Person and Mr. Hochman are the managing members of OMV GP. Reporting Person and Mr. Hochman jointly exercise dispositive and voting power over the shares owned by OMV Reserve. Each of Reporting Person, Mr. Hochman and OMV GP disclaims, for purposes of Section 16, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Reporting Person, Mr. Hochman or OMV GP is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.
- F7The securities are directly held by Accelerated Technologies, Inc. ("ATI"). Reporting Person and Mr. Hochman jointly exercise dispositive and voting power over the shares owned by ATI. Each of Reporting Person and Mr. Hochman disclaims, for purposes of Section 16, beneficial ownership of such securities, except to the extent of his indirect pecuniary interest therein, and this report shall not be deemed an admission that either Reporting Person or Mr. Hochman is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.